Physicochemical analyses of phase transition and dehydration processes of a new oral 1 β-methylcarbapenem antibiotic agent, CS-834

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 12, 2002, Pages 1570-1573

  Kobayashi, Katsuhiro ^a,b   Fukuhara, Hiroshi ^a   Kawamoto, Isao ^a   Hata, Tadashi ^a   Sekine, Akiko ^b   Uekusa, Hidehiro ^b   Ohashi, Yuji ^b  

^a DAIICHI SANKYO CO   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

1 methylcarbapenem; Dehydration; Phase transition; Powder X ray diffractometry; Pseudopolymorph; Thermal analysis

Indexed keywords

1BETA METHYLCARBAPENEM DERIVATIVE; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE;

ARTICLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; HIGH TEMPERATURE; HYDRATION; INFRARED SPECTROSCOPY; MELTING POINT; MICROSCOPY; MOISTURE; MOLECULAR SIZE; MOLECULE; PHASE TRANSITION; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; TEMPERATURE DEPENDENCE; TEMPERATURE MEASUREMENT; THERMODYNAMICS; THERMOGRAVIMETRY; TITRIMETRY; X RAY POWDER DIFFRACTION; CHEMISTRY; DESICCATION; DRUG DESIGN; DRUG STABILITY; ORAL DRUG ADMINISTRATION; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAPENEMS; DESICCATION; DRUG DESIGN; DRUG STABILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TITRIMETRY; X-RAY DIFFRACTION;

EID: 1842865281     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.1570     Document Type: Article

References (19)

1. Sugi K., Itaya N., Katsura T., Igi M., Yamazaki S., Ishibashi T., Yamaoka T., Kawada Y., Tagami Y., Otsuki M., Ohshima T., Chem. Pharm. Bull., 48, 529-536 (2000).
2. Botha S. A., Caira M. R., Guillovy J. K., Lotter A. P., J. Pharm. Sci., 78, 28-34 (1989).
3. Yajima K., Okihara A., Hoshino M., Chem. Pharm. Bull., 45, 1677-1682 (1997).
4. Otsuka M., Matsumoto T., Kaneniwa N., Chem. Pharm. Bull., 34, 1784-1793 (1986).
5. Chan H. K., Doelker E., Drug Dev. Ind. Pharm., 11, 315-332 (1985).
6. Matsunaga J., Nambu N., Nagai T., Chem. Pharm. Bull., 24, 1169-1172 (1976).
7. Kimura K., Hirayama F., Uekawa K., J. Pharm. Sci., 88, 385-391 (1999).
8. Kato Y., Okamoto Y., Nagasawa S., Ueki T., Chem. Pharm. Bull., 29, 3410-3413 (1981).
9. Aguiar A. J., Krc J. Jr., Kinkel A. W., Samyn J. C., J. Pharm. Sci., 56, 847-853 (1967).
10. Matsuda Y., Tatsumi E., Chiba E., Miwa Y., J. Pharm. Sci., 73, 1453-1460 (1984).
11. Bettinetti G., Mura P., Sorrenti M., Faucci M. T., Negri A., J. Pharm. Sci., 88, 1133-1139 (1999).
12. Uchida T., Yonemochi E., Oguchi T., Terada K., Yamamoto K., Nakai Y., Chem. Pharm. Bull., 41, 1632-1635 (1993).
13. Imaizumi H., Nanbu N., Nagai T., Chem. Pharm. Bull., 28, 2565-2569 (1980).
14. Nakamachi H., Yamaoka T., Wada Y., Miyata K., Chem. Pharm. Bull., 30, 3685-3694 (1982).
15. Miyauchi M., Endo R., Hisaoka M., Yasuda H., Kawamoto I., J. Antibiot., 50, 429-439 (1997).
16. Kobayashi K., Fukuhara H., Ito S., Furukawa Y., Hata T., "The Annual Meeting of the Crystallographic Society of Japan (in Yokohama)," 1998, p. No. 28.
17. Kobayashi K., Fukuhara H., Kawamoto I., Furukawa Y., Hata T., Anal. Sci., 16, 555-556 (2000).
18. Kobayashi K., Fukuhara H., Kawamoto I., Ito S., Hata T., Anal. Sci., 17, 357-358 (2001).
19. Kitaoka H., Wada C., Moroi R., Hakusui H., Chem. Pharm. Bull., 43, 649-653 (1995).